Search For "immunogenicity"
Novo Medi Sciences Launches NEXIPOX PLUS®, a Next-Generation Varicella Vac
Updated : 1 month, 2 weeks ago IST
Mumbai (Maharashtra) [India] January 23: Novo Medi Sciences Pvt. Ltd. (Novo Group), a legacy-driven pharmaceutical company with 80 years of expertise in developing niche biological products such as vaccines and life-saving critical care solutions, has announced the launch of NEXIPOX PLUS®, t
Read More
Expert committee approves Bharat Biotech International's proposal to condu
Updated : 1 year, 10 months ago IST
The Subject Expert Committee (SEC) under the Central Drug Standard Control Organisation (CDSCO) has approved vaccine major Bharat Biotech International's proposal to conduct the Phase II clinical trial of Mycobacterium Tuberculosis (Live Attenuated) Vaccine to assess the safety and immunogen
Read More
Corbevax COVID vaccine is safe, offers high antibody levels: NTAGI chief
Updated : 4 years ago IST
New Delhi [India], February 15 (ANI): India's third homegrown COVID-19 vaccine Corbevax is safe and offers good immunogenicity and higher antibody levels than some other vector vaccines, said Dr N K Arora, Chairman, India's COVID-19 Working group of National Technical Advisory Group on immun
Read More
Covaxin trials on children show similar results as on adults, says expert
Updated : 4 years, 5 months ago IST
New Delhi [India], October 11 (ANI): As India's largest COVID-19 vaccination drive is underway, an AIIMS professor has claimed that the latest trials show that the safety and immunogenicity of India's indigenous COVID-19 vaccine--Covaxin--are almost the same in children, as adults above 1
Read More
Novavax begins early-stage trial for combined influenza, COVID-19 vaccines
Updated : 4 years, 6 months ago IST
Washington [US], September 8 (ANI): US firm Novavax on Wednesday announced that it has initiated an early stage to evaluate the safety and immunogenicity of a combined flu Novavax' seasonal influenza and COVID-19 vaccines.
Read More
Mix of Covishield, Covaxin yields better results: ICMR Study
Updated : 4 years, 7 months ago IST
New Delhi [India], August 8 (ANI): The Indian Council of Medical Research (ICMR) has revealed in its study that the combination of Covaxin and Covishield vaccines, the two main vaccines of the COVID-19 vaccination programme, conducted on 18 people, has elicited better safety and immunogen
Read More
Zydus Cadila submits additional data to DCGI for its COVID-19 vaccine: Sou
Updated : 4 years, 7 months ago IST
New Delhi [India], July 27 (ANI): Ahmedabad-based Zydus Cadila has submitted additional data related to immunogenicity and safety, on its three-dose COVID-19 vaccine ZyCoV-D, to India's drug regulator Drugs Controller General of India (DCGI), sources said on Tuesday.
Read More
Zydus Cadila expected to provide additional data on Covid-19 vaccine to DC
Updated : 4 years, 7 months ago IST
New Delhi [India], July 20 (ANI): Emergency approval for Zydus Cadila's Covid-19 vaccine may take a few more days with the Ahmedabad-based pharma company set to submit additional data related to immunogenicity and safety of its Zycov-D vaccine to the Drugs Controller General of India (DCGI)
Read More
Sanofi, GSK receive approval for Phase 3 trial of COVID vaccine in India
Updated : 4 years, 8 months ago IST
New Delhi [India], July 8 (ANI): French pharmaceutical company Sanofi and its British partner GSK (GlaxoSmithKline plc) received approval for their Phase 3 clinical study in India, to assess the safety, efficacy and immunogenicity of their adjuvanted recombinant-protein COVID-19 vaccine cand
Read More
SEC recommends Dr Reddy's to submit additional data for EUA of Sputnik V C
Updated : 5 years ago IST
New Delhi [India], February 24 (ANI): The Central Drugs Standard Control Organisation's (CDSCO) Subject Expert Committee (SEC) has recommended additional immunogenicity data from Dr Reddy's Laboratories which applied to the national drugs regulator seeking emergency use approval for Sputnik
Read More
Pfizer showed no plans to generate safety data in Indian population for CO
Updated : 5 years, 1 month ago IST
New Delhi [India] February 5 (ANI): The subject expert panel of Drugs Controller General of India did not recommend granting emergency use authorisation to Pfizer's COVID-19 vaccine noting that the firm has not proposed plans to generate safety and immunogenicity data concerning Indian popu
Read More
COVAXIN shows high safety, immunogenicity during phase 1 clinical trial: L
Updated : 5 years, 1 month ago IST
New Delhi [India], January 22 (ANI): In a remarkable finding, India's indigenous Covid-19 vaccine--COVAXIN developed by the Bharat Biotech and Indian Council of Medical Research (ICMR) has shown high safety and immunogenicity during the phase 1 clinical trial, according to the findings of th
Read More